Industry News
Pharmaceutical Industry News
As trial complexity rises, finance…
As trial complexity rises, finance modernization is becoming a strategic imperative for speed, site trust and operational resilience.
With a midstage peek at the data…
With a midstage peek at the data on Veradermics’ oral formulation of the molecule behind the ubiquitous hair regrowth treatment Rogaine, analysts are feeling increasingly confident that the company is a cut above the rest
Johnson & Johnson reported its…
Johnson & Johnson reported its fifth straight quarter with revenue growth of at least 6%. This surge has come despite the loss of patent protection for Stelara. Compensating for the shortfall is Tremfya, which topped
The clinical blueprint for Merck…
The clinical blueprint for Merck & Co.’s prized TROP2-directed antibody-drug conjugate, sac-TMT, could add a missing piece thanks to a landmark achieved by its partner, Kelun-Biotech.
Two years after its central role…
Two years after its central role in the Paris Olympics in France, Sanofi is back in its home country once again supporting sport.
Generative AI specialist Insilico…
Generative AI specialist Insilico Medicine has teamed up with another biopharma company, this time CDMO Bora Pharmaceuticals. The collaboration could ultimately be worth $2.5 billion if milestones are reached.
The FDA has approved a new small…
The FDA has approved a new small molecule inhibitor from Celcuity with blockbuster potential that could become a new standard-of-care for patients with breast cancer.
In an era of continued addiction…
In an era of continued addiction risk, non-opioid pain therapies are gaining traction, but access barriers persist. Here’s what’s standing in the way.
Senior Director Kate Woda breaks…
Senior Director Kate Woda breaks down what attendees can expect at the Partnerships with Sites Summit, happening Sept. 14, 2026 in Boston, MA.
Chai Discovery, an A.I. Drug Start-Up, Raises $400 Million
The fund-raising values the company at $3.8 billion and underscores investor interest in using artificial intelligence to tackle problems like drug discovery.
Dr. Rana McKay speaks to the…
Dr. Rana McKay speaks to the ARANOTE trial of NUBEQA® (darolutamide) and what the data mean for patients, doctors, and care providers.
Huyabio has scored a win in the…
Huyabio has scored a win in the largest oncology study it has undertaken in its 22 years, as its oral histone deacetylase inhibitor HBI-8000 has succeeded in combination with Bristol Myers Squibb’s Opdivo in a
AstraZeneca is shelling out up to…
AstraZeneca is shelling out up to $1.5 billion to lock down global rights to an EGFR lung cancer drug from Dizal Pharmaceutical, deepening its ties with a Chinese biotech it spun out nearly a decade
Real Chemistry has launched…
Real Chemistry has launched artificial intelligence tools for healthcare commercialization, continuing its embrace of technology tipped to transform biopharma marketing.
In the second of a new series of…
In the second of a new series of interviews with top executives from leading healthcare and comms agencies, Fierce Pharma Marketing sat down with London-based Havas SO’s managing director, Joanna Quade and Creative Director, Lucy
After speedrunning a series of…
After speedrunning a series of major manufacturing milestones in the past year-and-a-half, the “biotech floodgates” have opened for Cellares, the automated cell therapy manufacturing specialist’s co-founder and CEO told Fierce Pharma Manufacturing.
Insulet and Calm are integrating…
Insulet and Calm are integrating mental health care into diabetes treatment with a series of mindfulness, meditation and sleep tools specifically tailored to the diabetes community.
The FDA has proposed a streamlined…
The FDA has proposed a streamlined pathway for registering production facilities that operate under a “hub-and-spoke” model. The agency has also proposed clarifying the registration requirements for foreign manufacturers, especially those who make active pharmaceutical
Even as the effort has met with…
Even as the effort has met with fierce pushback, German lawmakers late Friday voted to pass health insurance reforms aiming at cutting healthcare costs, in part by hiking up mandatory rebates that pharmas must pay
In what GSK says represents a…
In what GSK says represents a potential way to transform treatment for patients with certain types of rectal cancer, the company’s Jemperli has met the main goal of a phase 2 trial, teeing up an